BARCLAYS PLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,416
+9.5%
155,245
+27.0%
0.00%0.0%
Q2 2023$1,293
-53.5%
122,267
-46.2%
0.00%0.0%
Q1 2023$2,778
+20.3%
227,115
+22.1%
0.00%0.0%
Q4 2022$2,309
-99.9%
186,049
-19.3%
0.00%
-66.7%
Q3 2022$3,149,000
+69.3%
230,542
+127.0%
0.00%
+200.0%
Q2 2022$1,860,000
+85.3%
101,552
+62.5%
0.00%0.0%
Q1 2022$1,004,000
-71.5%
62,489
-75.1%
0.00%0.0%
Q4 2021$3,520,000
+126.7%
251,292
+203.0%
0.00%0.0%
Q3 2021$1,553,000
-0.4%
82,935
+11.0%
0.00%0.0%
Q2 2021$1,559,000
-59.5%
74,746
-45.1%
0.00%
-50.0%
Q1 2021$3,852,000
+448.7%
136,202
+533.4%
0.00%
Q4 2020$702,000
-80.9%
21,504
-82.1%
0.00%
-100.0%
Q3 2020$3,681,000
+164.8%
120,146
+40.9%
0.00%
+100.0%
Q2 2020$1,390,000
+286.1%
85,278
+135.9%
0.00%
Q1 2020$360,000
-25.6%
36,148
+2.6%
0.00%
Q4 2019$484,000
+86.9%
35,225
+106.6%
0.00%
Q3 2019$259,000
-39.3%
17,049
-21.4%
0.00%
Q2 2019$427,000
+221.1%
21,679
+171.1%
0.00%
Q1 2019$133,000
-41.7%
7,996
-38.3%
0.00%
Q3 2018$228,000
+121.4%
12,965
+128.3%
0.00%
Q2 2018$103,000
-38.7%
5,680
-36.7%
0.00%
Q1 2018$168,000
+104.9%
8,977
+67.0%
0.00%
Q4 2017$82,000
+1071.4%
5,377
+1097.6%
0.00%
Q3 2017$7,000449
+3981.8%
0.00%
Q2 2017$0
-100.0%
11
-99.8%
0.00%
Q1 2017$60,0006,8000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders